Efficacy and safety of intravenous recombinant tissue plasminogen activator in mild ischaemic stroke: a meta-analysis

The benefits and safety of intravenous recombinant tissue plasminogen activator (IV-tPA) for patients with mild ischaemic stroke (MIS) are still unclear. The objective of this meta-analysis was to evaluate the efficacy and safety of IV-tPA as treatment for patients with MIS. We performed a systemati...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Shoujiang, Saxena, Anubhav, Wang, Xia, Tan, WeeYong, Han, Qiao, Cao, Yongjun, Liu, Chun-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870640/
https://www.ncbi.nlm.nih.gov/pubmed/29600004
http://dx.doi.org/10.1136/svn-2017-000106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870640/
https://www.ncbi.nlm.nih.gov/pubmed/29600004
http://dx.doi.org/10.1136/svn-2017-000106

Ejemplares similares